Webinar: Rethink your commercialization strategy

Do you have the right resources to deliver disruptive innovation? As commercialization solutions become more sophisticated, can you keep pace on your own?


Join us to rethink commercialization strategy and the role of the right partner. From drug development through post-launch, see how commercialization solutions can be reimagined and integrated at every step of a drug’s journey to market. Learn how to rethink logistics and deliver clinical trial meds direct to patients. Reimagine field and patient services to remove access barriers even when patients are getting virtual care. Explore market-moving channel strategies and innovative logistics. And hear about it all from the team that designs and delivers commercialization strategies and solutions for our manufacturer partners every day.


It’s time to rethink your approach to commercialization.

Donna Gilbert

Vice President, Manufacturer Commercialization Strategies

AmerisourceBergen

Donna Gilbert is Vice President, Manufacturer Commercialization Strategies, and is responsible for developing strategic drug manufacturing partnerships for the AmerisourceBergen enterprise. By leveraging distribution, consulting services, patient access, provider solutions and pharmacy solutions, Donna creates innovative solutions for the pharmaceutical and specialty manufacturer. She previously served as Vice President for Xcenda’s Commercial Client Strategies group, where she led the business development team to increase market share and drive growth.

Nancy Hoak

Senior Director, Manufacturer Commercialization Strategies

AmerisourceBergen

Nancy Hoak is Senior Director, Manufacturer Commercialization Strategies. She is a member of the Commercialization Services & Animal Health leadership team, responsible for strategic account management and commercialization strategy development on behalf of the AmerisourceBergen enterprise for specialty and branded products. She joined AmerisourceBergen as Director, New Business Development within the Lash Group. Nancy has developed and operated several programs to support rare disease throughout her career and served as a corporate committee chair for a rare disease advocacy organization.

Glen Martin

Vice President, Manufacturer Commercialization Strategies

AmerisourceBergen

Glen Martin is Vice President, Manufacturer Commercialization Strategies, responsible for leading integrated business development and strategic account management on behalf of the AmerisourceBergen enterprise for specialty and branded manufacturers. Glen joined AmerisourceBergen as Vice President, Strategic Account Lead within the Brand/Specialty Manufacturer segment where he partnered with a select group of key manufacturers to understand their business and create awareness for the optimal solutions from AmerisourceBergen’s vast commercialization service portfolio.

NOW ON-DEMAND

Register now for this webinar

© 2021 Questex LLC, All right reserved.

685 Third Avenue, 21st Floor New York, NY 10017

Reproduction in whole or part is prohibited.